Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

NCT02614937 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: ranibizumab
DRUG: Squalamine Lactate Ophthalmic Solution, 0.2%

Sponsor

Ohr Pharmaceutical Inc.

Collaborators

[object Object]